These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38428702)

  • 21. Eradicating the tumor "seeds": nanomedicines-based therapies against cancer stem cells.
    Li L; Ni R; Zheng D; Chen L
    Daru; 2023 Jun; 31(1):83-94. PubMed ID: 36971921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.
    Ruiu R; Tarone L; Rolih V; Barutello G; Bolli E; Riccardo F; Cavallo F; Conti L
    Prog Mol Biol Transl Sci; 2019; 164():119-188. PubMed ID: 31383404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
    Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
    Front Immunol; 2020; 11():1280. PubMed ID: 32849491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer cell-based immunotherapy: From transplantation toward targeting cancer stem cells.
    Dianat-Moghadam H; Rokni M; Marofi F; Panahi Y; Yousefi M
    J Cell Physiol; 2018 Jan; 234(1):259-273. PubMed ID: 30144312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective.
    Donini C; Rotolo R; Proment A; Aglietta M; Sangiolo D; Leuci V
    Cells; 2021 Mar; 10(3):. PubMed ID: 33806296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A promising antitumor method: Targeting CSC with immune cells modified with CAR.
    Huang B; Miao L; Liu J; Zhang J; Li Y
    Front Immunol; 2022; 13():937327. PubMed ID: 36032145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy.
    Zhang S; Yang Z; Qi F
    Mol Biol Rep; 2020 Feb; 47(2):1435-1443. PubMed ID: 31838656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Advances in Cancer Stem Cell-Targeted Immunotherapy.
    Badrinath N; Yoo SY
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30841635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical cancer stem cells: opportunities and challenges.
    Chhabra R
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1889-97. PubMed ID: 25563493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective.
    Gammaitoni L; Leuci V; Mesiano G; Giraudo L; Todorovic M; Carnevale-Schianca F; Aglietta M; Sangiolo D
    Expert Opin Biol Ther; 2014 Sep; 14(9):1259-70. PubMed ID: 24835841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cells targets and combined therapies to prevent cancer recurrence.
    Raghav PK; Mann Z
    Life Sci; 2021 Jul; 277():119465. PubMed ID: 33831426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of cancer stem cells in progressive growth and resistance of ovarian cancer: true or fiction?].
    Bar JK; Grelewski P; Lis-Nawara A; Drobnikowska K
    Postepy Hig Med Dosw (Online); 2015 Sep; 69():1077-86. PubMed ID: 26400893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.
    Zhao Q; Zong H; Zhu P; Su C; Tang W; Chen Z; Jin S
    Exp Hematol Oncol; 2024 Jan; 13(1):6. PubMed ID: 38254219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy.
    Dianat-Moghadam H; Mahari A; Salahlou R; Khalili M; Azizi M; Sadeghzadeh H
    Stem Cell Res Ther; 2022 Apr; 13(1):150. PubMed ID: 35395787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses.
    Crupi MJF; Bell JC; Singaravelu R
    Stem Cells; 2019 Jun; 37(6):716-723. PubMed ID: 30875126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells.
    Cheng JY; Hung JT; Lin J; Lo FY; Huang JR; Chiou SP; Wang YH; Lin RJ; Wu JC; Yu J; Yu AL
    Front Immunol; 2021; 12():791551. PubMed ID: 35046949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Importance of Cancer Stem Cells in Gastrointestinal Cancers.
    Dindar DA; Albayrak G; Ozet A
    Crit Rev Oncog; 2019; 24(1):55-59. PubMed ID: 31679220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of cancer stem cell therapy.
    Akbar Samadani A; Keymoradzdeh A; Shams S; Soleymanpour A; Elham Norollahi S; Vahidi S; Rashidy-Pour A; Ashraf A; Mirzajani E; Khanaki K; Rahbar Taramsari M; Samimian S; Najafzadeh A
    Clin Chim Acta; 2020 Nov; 510():581-592. PubMed ID: 32791136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.